5648
M. Petrini, R. R. Shaikh / Tetrahedron Letters 49 (2008) 5645–5648
(m, 1H), 3.87–4.03 (m, 2H), 4.09–4.20 (m, 1H), 7.08 (t, 1H, J = 7.3 Hz), 7.16 (t,
Díaz, A.; Guillin, J. J.; Blanco, O.; Ruiz, M.; Ojea, V. J. Org. Chem. 2006, 71, 6958–
6974; (c) Han, L.; Hiratake, J.; Tachi, N.; Suzuki, H.; Kumagai, H.; Sakata, K.
Bioorg. Med. Chem. 2006, 14, 6043–6054.
1H, J = 7.3 Hz), 7.35–7.50 (m, 4H), 7.65–7.69 (m, 2H), 8.01 (d, 1H, J = 8.1 Hz),
8.70 (s, 1H). 13C NMR (100 MHz, CDCl3) d: 14.1, 16.4 (d, 3J(CP) = 5.3 Hz,
CH3CH2O), 16.6 (d, 3J(CP) = 5.3 Hz, CH3CH2O), 22.5, 27.3, 27.5, 28.2, 31.3, 36.1
(d, 1J(CP) = 142.7 Hz, CHP), 61.7 (d, 2J(CP) = 7.1 Hz, CH3CH2O), 61.8 (d,
2J(CP) = 7.1 Hz, CH3CH2O), 61.9, 62.0, 62.3, 62.4, 110.9, 119.6, 122.12, 128.1,
128.3, 128.7, 128.9, 129.1, 133.1, 136.3, 137.3, 137.5. Compound 8h: Oil. IR
(cmꢁ1, neat): 3645, 1277, 1179. 1H NMR (400 MHz, CDCl3) d: 0.70 (t, 3H,
J = 7.3 Hz), 1.07 (t, 3H, J = 7.3 Hz), 1.23 (t, 3H, J = 6.9 Hz), 2.05–2.18 (m, 1H),
2.21–2.38 (m, 1H), 3.40 (ddd, 1H, J = 4.3, 11.6, 23.5 Hz), 3.71–3.80 (m, 1H),
3.82–4.04 (m, 2H), 4.07–4.20 (m, 1H), 7.09 (t, 1H, J = 6.8 Hz), 7.16 (t, 1H,
J = 6.8 Hz), 7.38–7.51 (m, 4H), 7.63–7.66 (m, 2H), 8.02 (d, 1H, J = 8.1 Hz), 8.73 (s,
1H). 13C NMR (100 MHz, CDCl3) d: 12.7, 12.9, 16.5 (d, 3J(CP) = 5.3 Hz, CH3CH2O),
16.6 (d, 3J(CP) = 5.3 Hz, CH3CH2O), 21.8, 38.1 (d, 1J(CP) = 142.7 Hz, CHP), 61.7 (d,
2J(CP) = 7.6 Hz, CH3CH2O), 62.3 (d, 2J(CP) = 7.6 Hz, CH3CH2O), 111.0, 119.5,
122.1, 128.1, 128.9, 129.2, 133.0, 136.3, 136.4. Compound 8k: mp 144–146. IR
(cmꢁ1, KBr): 3648, 1715, 1270, 1178. 1H NMR (400 MHz, CDCl3) d: (mixture of
rotamers) 0.82 (t, 1.5H, J = 7.2 Hz), 0.83 (t, 1.5H, J = 7.3 Hz), 1.30 (t, 1.5H,
J = 7.3 Hz), 1.39 (t, 1.5H, J = 7.3 Hz), 2.20–2.38 (m, 1H), 2.40–2.56 (m, 0.5H),
2.57–2.65 (m, 0.5H), 3.53 (d, 1.5H, J = 10.7 Hz), 3.74 (d, 1.5H, J = 10.7 Hz), 3.77
(d, 1.5H, J = 11.3 Hz), 3.80 (d, 1.5H, J = 11.3 Hz), 4.11–4.22 (m, 2H), 4.26–4.40
(m, 2H), 4.57–4.67 (m, 0.5H), 5.60 (dd, 0.5H, J = 4.2, 11.5 Hz), 7.08–7.15 (m, 1H),
7.24–7.45 (m, 2H), 8.05–8.09 (m, 1H), 9.08 (s, 0.5H) 9.14 (s, 0.5H). 13C NMR
(100 MHz, CDCl3) d: 12.1, 12.9, 13.1, 14.5, 14.6, 20.4, 21.8, 22.4, 22.5, 36.6 (d,
1J(CP) = 140.4 Hz, CHP), 52.8 (d, 2J(CP) = 7.6 Hz, CH3O), 53.1 (d, 2J(CP) = 7.6 Hz,
CH3O), 61.1, 61.2, 65.3, 112.1, 112.3, 114.0, 120.5, 121.3, 123.8, 124.1, 125.8,
125.9, 128.9, 129.2, 135.7, 136.1, 136.3, 144.2, 161.2, 162.2.
11. (a) Yanagisawa, A.; Arai, T. Chem. Commun. 2008, 1165–1172; (b) Caminade, A.
M.; Servin, P.; Laurent, R.; Majoral, J. P. Chem. Soc. Rev. 2008, 37, 56–67; (c)
Gluek, D. S. Synlett 2007, 2627–2634.
12. General procedure for the preparation of 3-(1-diphenylphosphinoalkyl) indoles 10.
Following the procedure reported in method B, diphenylphosphine
9
(1.1 mmol) and sulfonyl indole 6 (1 mmol) were made to react with KF on
basic alumina (2 g) in THF (5 mL) for 4 h at room temperature. Selected data of
compounds prepared: compound 10a: Oil. IR (cmꢁ1, neat): 3642, 1423. 1H NMR
(400 MHz, CDCl3) d: 2.01–2.11 (m, 1H), 2.20–2.31 (m, 1H), 2.40–2.48 (m, 1H),
2.71–2.79 (m, 1H), 3.76–3.81 (m, 1H), 6.91–7.60 (m, 18H), 7.73–7.76 (m, 2H),
9.53 (s, 1H). 13C NMR (100 MHz, CDCl3) d: 31.7, 33.4 (d, 3J(CP) = 13.0 Hz,
CH2Ph), 35.4 (d, 1J(CP) = 71.0 Hz, CHP), 109.0, 111.6, 118.5, 119.2, 121.6, 124.8,
124.9, 126.2, 128.0, 128.1, 128.2, 128.4, 128.8, 128.9, 129.1, 130.8, 130.9, 131.2,
131.3, 131.5, 132.1, 132.6, 136.0, 141.2. Compound 10c: mp 242–244. IR (cmꢁ1
,
KBr): 3648, 1428. 1H NMR (400 MHz, CDCl3) d: 0.69 (t, 3H, J = 6.8 Hz), 1.02–
1.19 (m, 5H), 1.20–1.33 (m, 1H), 1.82–1.94 (m, 1H), 2.51–2.65 (m, 1H), 3.87 (dt,
1H, J = 3.0, 12.4 Hz), 7.00–7.42 (m, 12H), 7.45–7.59 (m, 4H), 7.73–7.82 (m, 2H),
8.23 (d, 1H, J = 7.7 Hz), 8.43 (s, 1H). 13C NMR (75 MHz, CDCl3) d: 14.1, 22.5,
27.7, 28.1, 28.3, 31.6, 39.1 (d, 1J(CP) = 106.4 Hz, CHP), 110.7, 120.0, 122.4, 123.4,
127.8, 128.0, 128.2, 128.7, 128.9, 129.1, 131.0, 131.1, 131.3, 131.7, 131.8, 133.1,
133.4, 134.3, 136.3, 137.3, 137.5.
13. (a) Léautey, M.; Castelot-Deliencourt, G.; Jubault, P.; Pannecoucke, X.; Quirion,
J.-C. Tetrahedron Lett. 2002, 43, 9237–9240; (b) Minami, T.; Okada, Y.; Otaguro,
T.; Tawaraya, S.; Furuichi, T.; Okauchi, T. Tetrahedron: Asymmetry 1995, 6,
2469–2474.
10. (a) Foss, F. W.; Snyder, A. H.; Davis, M. D.; Rouse, M.; Okusa, M. D.; Lynch, K. R.;
MacDonald, T. L. Bioorg. Med. Chem. 2007, 15, 663–677; (b) Fernández, M. C.;
14. Bergbreiter, D. E.; Lalonde, J. J. J. Org. Chem. 1987, 52, 1601–1603.